Company K Partners
Funding rounds backed by Company K Partners.
- Funding disclosed in full
- $149M
- Median round
- $74.5M
- Rounds in calculation
- 2
| Company | Round | Market | Investors | Announced | Details |
|---|---|---|---|---|---|
| KaliVir Immunotherapeutics Develops oncolytic immunotherapies for patients with advanced solid tumors | $14MSeries A | BiotechUnited States | |||
| XCENA Builds CXL computational memory chips and SDK for AI infrastructure in hyperscalers, telcos, and research | $135MSeries B | AIUnited States | 22 participantsAtinum InvestmentCompany K PartnersCorstone AsiaDSC InvestmentIMM InvestmentK2 Investment PartnersKDB CapitalKiwoom InvestmentKolon InvestmentKorea Development BankKyobo LifeKyobo SecuritiesLB InvestmentMirae Asset CapitalMirae Asset Venture InvestmentsPartners InvestmentPremier PartnersSBI InvestmentShinhan Venture InvestmentSTIC VenturesSV InvestmentWonik Investment Partners |